Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.64 |
| ▸ | AGXT | P21549 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 6/20 | 0.49 |
| ▸ | HTR1A | P08908 | 5/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 4/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | FLT3 | P36888 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515109 | 1.00 | LOXL2 (0.64) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| Hydrogen Sulfide SCHEMBL27542781 | 0.98 | LOXL2 (0.62) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| Hydrochloric Acid SCHEMBL29122771 | 0.96 | LOXL2 (0.60) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| Dimethylamine SCHEMBL25351475 | 0.94 | LOXL2 (0.58) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| SCHEMBL20280743 | 0.83 | FLT3 (0.56) | LOXL2AGXTSMN1; SMN2FLT3KDM4E | |
| SCHEMBL28087518 | 0.83 | LOXL2 (0.46) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| SCHEMBL6013090 | 0.83 | LOXL2 (0.60) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| SCHEMBL14075637 | 0.82 | LOXL2 (0.69) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| SCHEMBL11616186 | 0.81 | LOXL2 (0.53) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B | |
| SCHEMBL1287509 | 0.80 | LOXL2 (0.56) | LOXL2AGXTSMN1; SMN2L3MBTL1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122133-A1 | Selective Transition Metal Catalyzed Deuterium Incorporation Into Alkyne and Alkene Functionalities | MARQUETTE UNIVERSITY | 2025-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122133-A1 | Selective Transition Metal Catalyzed Deuterium Incorporation Into Alkyne and Alkene Functionalities | HDHD5, DDT, AHR | LOXL2 3808/4885AGXT 1750/4885SMN1; SMN2 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.